Dao K-HT, Tyner JW. What’s different about atypical CML and chronic neutrophilic leukemia? Hematology Am Soc Hematol Educ Program. 2015;2015:264-271.

Ítems similars

• Sanz GF. In MDS, is higher risk higher reward? Hematology Am Soc Hematol Educ Program. 2019;2019:381-390.
  Publicat: (2020)
• Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Hematology Am Soc Hematol Educ Program. 2017;2017:400-405.
  Publicat: (2018)
• Scherber RM, Mesa RA. Managing myelofibrosis (MF) that “blasts” through: advancements in the treatment of relapsed/refractory and blast-phase MF. Hematology Am Soc Hematol Educ Program. 2018;2018:118-126.
  Publicat: (2019)
• Erratum: Relative sound localisation abilities in human listeners [J. Acoust. Soc. Am. 138, 674–686 (2015)]
  per: Wood, Katherine C., et al.
  Publicat: (2016)
• Diagnosis and Treatment of Chronic Myeloid Leukemia (CML) in 2015
  per: Thompson, Philip A, et al.
  Publicat: (2015)